Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients

 

^* First authors are equal contributors.

• References

• 1 Blann AD, Dunmore S. Arterial and venous thrombosis in cancer patients. Cardiol Res Pract 2011; 2011: 394740.
• 2 Di Nisio M, Ferrante N, De Tursi M. et al. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Thromb Haemost 2010; 104: 1049-1054.
• 3 Liebman HA, Khorana AA, Kessler CM. Clinical Roundtable Monograph: The Oncologist’s Role in the Management of Venous Thromboembolism. Clin Adv Hematol Oncol 2011; 9: 1-15.
• 4 Guyatt GH, Akl EA, Crowther M. et al. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th Edition). Chest 2012; 141: 7S-47S.
• 5 Agterof MJ, van Bladel ER, Schutgens RE. et al. Risk stratification of patients with pulmonary embolism based on pulse rate and D-dimer concentration. Thromb Haemost 2009; 102: 683-687.
• 6 Ay C, Dunkler D, Marosi C. et al. Prediction of venous thromboembolism in cancer patients. Blood 2010; 116: 5377-5382.
• 7 Douma RA, van Sluis GL, Kamphuisen PW. et al. Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients. Explanations and potential ameliorations. Thromb Haemost 2010; 104: 831-836.
• 8 Legnani C, Cini M, Scarvelis D. et al. Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil®D-dimer HS 500, in patients with clinically suspected venous thromboembolism. Thromb Res 2010; 125: 398-401.
• 9 Ferroni P, Martini F, Portarena I. et al. Novel High-Sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in lung cancer patients. Clin Lung Cancer, epub ahead of print. 2012